| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 1312-1319, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
G Gaidano, EW Newcomb, JZ Gong, V Tassi, A Neri, A Cortelezzi, R Calori, L Baldini and R Dalla-Favera
Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
B cell chronic lymphocytic leukemia (B-CLL) represents the most frequent adult leukemia in the Western world. The molecular pathogenesis of B-CLL is largely unknown. Although initial reports on small panels of cases had suggested a role for Bcl-1 and Bcl-2 oncogene activation in B-CLL, later investigations failed to confirm these data. Among tumor suppressor genes, p53 mutations have been reported in a fraction of cases. In this study, we have attempted a conclusive definition of the involvement of dominantly acting oncogenes (Bcl-1 and Bcl-2) and tumor suppressor loci (p53, 6q-) in 100 cases of B-CLL selected for their CD5 positivity and Rai's stage (0 to IV). Rearrangements of Bcl-1 and Bcl-2 and deletions of 6q and 17p were analyzed by Southern blot using multiple probes. Mutational analysis (single strand conformation polymorphism and polymerase chain reaction direct sequencing) was used to assay p53 inactivation. No alterations of Bcl-1 or Bcl-2 were detected in the 100 cases tested. Mutations of p53 were found in 10/100 cases without any significant association with clinical stage. Deletions of 6q were present in 4/100 cases. Overall, our data indicate that: 1) contrary to previous reports, Bcl-1 and Bcl- 2 rearrangements are not involved in CD5+ B-CLL pathogenesis and 2) p53 mutations are present in 10% of cases at all stages of the disease.
This article has been cited by other articles:
 |
|
 |
|
  G Kocjan BEST PRACTICE No 185 Cytological and molecular diagnosis of lymphoma J. Clin. Pathol., June 1, 2005; 58(6): 561 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Migliazza, F. Bosch, H. Komatsu, E. Cayanis, S. Martinotti, E. Toniato, E. Guccione, X. Qu, M. Chien, V. V. V. Murty, et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia Blood, April 1, 2001; 97(7): 2098 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Harris, H. Stein, S. E. Coupland, M. Hummel, R. D. Favera, L. Pasqualucci, and W. C. Chan New Approaches to Lymphoma Diagnosis Hematology, January 1, 2001; 2001(1): 194 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Schettino, A. Cerutti, N. Chiorazzi, and P. Casali Lack of Intraclonal Diversification in Ig Heavy and Light Chain V Region Genes Expressed by CD5+IgM+ Chronic Lymphocytic Leukemia B Cells: A Multiple Time Point Analysis J. Immunol., January 15, 1998; 160(2): 820 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lens, P. J.J.C. De Schouwer, R. A. Hamoudi, M. Abdul-Rauf, N. Farahat, E. Matutes, T. Crook, M. J.S. Dyer, and D. Catovsky p53 Abnormalities in B-Cell Prolymphocytic Leukemia Blood, March 15, 1997; 89(6): 2015 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Matolcsy, P. Casali, R. G. Nador, Y.-F. Liu, and D. M. Knowles Molecular Characterization of IgA- and/or IgG-Switched Chronic Lymphocytic Leukemia B Cells Blood, March 1, 1997; 89(5): 1732 - 1739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rozman and E. Montserrat Chronic Lymphocytic Leukemia N. Engl. J. Med., October 19, 1995; 333(16): 1052 - 1057. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
